Menu Close

Author: WorkCompAcademy

Applicant Attorney Faces State Bar Suspension

Former San Diego Chargers great Ron Mix, a member of the Pro Football Hall of Fame, pleaded guilty in federal court in Missouri to a tax fraud charge stemming from his post-football career as a California workers compensation lawyer.

Mix has been a successful workers compensation lawyers since his retirement from the game. Many of his clients are former professional athletes who made claims for injuries suffered during their playing days, usually years after their careers ended. Mix filed about 300 such cases in the final month before the law changed in late 2013, according to news reports at the time. But this federal criminal case was prosecuted in Kansas City because some of the clients referred to Mix lived in the Western District of Missouri. None of their names was released.

According to the plea agreement filed in federal court attorney Mix admitted the following, “Between October 18, 2010 and December 16, 2013 in the Western District of Missouri and elsewhere, the defendant, RONALD JACK MIX (“MIX”), doing business as the LAW OFFICES OF RON MIX, entered into an arrangement whereby INDIVIDUAL F, who is not an attorney, would refer professional athletes to MIX and the LAW OFFICES OF RON MIX, so that defendant, MIX, could file workers’ compensation claims in the state of California on behalf of these former professional athletes. MIX then agreed to make donations to a charity as directed by INDIVIDUAL F. The charity was THE SIXTH MAN FOUNDATION d/b/a PROJECT CONTACT AFRICA (“PCA”), a federally-registered tax exempt 501(c)(3) charity. The individuals referred were in need of the services provided by MIX, he was well-qualified to perform these services, and he properly performed the services to the individuals who were referred.”

“MIX admits that he wrote checks out of his personal bank account and his law firm’s bank account to the charity as directed by INDIVIDUAL F while the latter made referrals of potential workman’s compensation cases. These donative payments ranged anywhere from $5,000 to $25,000. Mix admits that some of the professional athletes referred to him by INDIVIDUAL F, resided in the Western District of Missouri, so that he could file workers’ compensation claims in the state of California on their behalf, which was a proper venue under California law.”

“MIX admits that from 2010 through 2013, he made approximately $155,000 in donations for client referrals.”

“MIX also admits that the payments to PCA were listed as “charitable contributions” on his Form 1040s, U.S. Individual Income Tax Returns, for calendar years 2010, 2011, 2012, and 2013.” However you cannot make a charitable contribution that is deductible when you get something back in return.

Jean Paul Bradshaw, Mix’s lawyer in Kansas City said Mix was told that the referrals would stop unless he donated more and more money to the charity. Prosecutors said that Mix’s donations ranged between $5,000 and $25,000.

The practice of paying a non-lawyer a fee for a referral is known as “capping,” and is illegal in California.

Mix’s guilty plea was reported to the State Bar Court on August 3, 2016.

This September the State Bar Court issued an interim suspension order that reads “Since respondent Ronald Jack Mix, State Bar Number 49663, has been convicted of violating title 26 United States Code section 7206(1) (filing a false income tax return), a felony that involves moral turpitude, it is ordered pursuant to Business and Professions Code section 6102 that respondent be suspended from the practice of law effective September 26, 2016, pending final disposition of this proceeding.”

He has not yet been sentenced in his federal criminal case.

United Nations Acts to Combat Antibiotic Overuse

The United Nations scheduled a pivotal meeting to combat antibacterial resistance during its General Assembly session, in a move that some are calling a “wakeup call” in the war against deadly infections that kill thousands of people a year.

The meeting in New York, is part of the week-long General Assembly, which convenes leaders from around the globe. It is the first high-level global meeting on antibiotic resistance and only the fourth time that the General Assembly has taken up a healthcare issue, with other meetings focusing on outbreaks such as Ebola.

“The disturbing truth is that the end of the antibiotic era is upon us in many parts of the world. But we are not too late,” said Michael Craig, senior adviser for antibiotic resistance coordination and strategy for the Centers for Disease Control and Prevention. “We need to continue to build on the momentum of our global commitment.”

Ahead of the United Nations General Assembly (UNGA) High-Level Meeting on Antimicrobial Resistance (AMR), 13 leading pharmaceutical companies today presented a new roadmap that lays out four key commitments they will deliver by 2020 to reduce AMR. The commitments follow the principles identified and agreed upon in the Industry Declaration made at the 2016 World Economic Forum in Davos earlier this year, and reflect the companies’ intent to continue to proactively contribute to the global efforts to address AMR. This unprecedented collaboration between the pharmaceutical companies marks a major milestone in the fight against AMR.

In presenting this roadmap, the signatory companies claim to demonstrate their shared ambition to overcome the staggering threat AMR represents for our society, economies, and citizens. The companies say they are committed to working to reduce the development of antimicrobial resistance, improve access to high-quality antibiotics, vaccines, and diagnostics, invest in R&D, and collaborate with governments and stakeholders to sustain those investments.

They hope to ensure antibiotics are used only by patients who need them, recognizing this requires concerted efforts from many stakeholders, through continued provider and patient education, an examination of the companies’ promotional activities, sharing of surveillance data with public health bodies and healthcare professionals, and collaboration with stakeholders to reduce uncontrolled antibiotic purchase;

Companies that have signed up to the scheme include leaders in both branded and generic drug production, including Pfizer, Merck, Novartis, GlaxoSmithKline and Allergan, as well as Indian drugmakers Cipla and Wockhardt.

Johan S. Bakken MD, PhD, FIDSA, President, Infectious Diseases Society of America, said: “Infectious diseases (ID) physicians see firsthand the devastating impact of antimicrobial resistance on our patients and public health. We are out of treatment options for increasing numbers of patients. IDSA welcomes the commitment of industry to address AMR and invest in the research and development of urgently needed new antimicrobial drugs, diagnostics and vaccines. Robust public private collaboration is essential for effective solutions to AMR.”

Though the problem of drug-resistant bacteria has been a feature of medicine since the discovery of penicillin in 1928, it has grown in recent years with the emergence of infections resistant to multiple drugs, such as MRSA.

So. Cal. Pain Medicine QME Arrested in Fraud Case

Detectives from the California Department of Insurance arrested Dr. Edward Albert G. Balbas, M.D., Chiropractor Jon Brunelle, D.C., and Alejandra Brunelle on felony insurance fraud charges for allegedly conspiring to submit more than 165 fraudulent bills to several health insurers totaling at least $380,000 over a three-year period.

According to department detectives, the three co-conspirators and owners of Corona Physical Medicine allegedly developed a scheme to mark up insurance reimbursement claims for laboratory tests in order to generate greater profits for themselves.

Evidence revealed the suspects paid Cell Science Systems, an out-of-state lab between $312 and $625 for the lab tests, but billed insurers $4,256 for the tests. The suspects were able to hide their alleged crime by claiming they processed and analyzed the blood tests through an in-house lab, so the insurers were unaware that the actual cost to process the lab tests was substantially lower.

Edward Albert G. Balbas is listed by the DWC as a QME in two specialities, Pain Medicine, and Physical Medicine and Rehabilitation. He is listed to perform QME evaluations in Corona, Irvine, Rancho Cucamonga, Colton and Indio. Board of Medicine records say he is a graduate of the University of Santo Tomas Faculty of Medicine in Sampaloc, Manila, Philippines. He has no prior disciplinary record on file with that agency.

“Patients should be able to trust that medical professionals are making medical decisions based on patient needs and conducting their practice ethically,” said Insurance Commissioner Dave Jones. “These defendants took extraordinary steps to hide their alleged crime and violate the trust of their patients and the medical profession.”

The suspects self-surrendered at the Riverside County Court and arranged for bail, which was set at $382,000 for each suspect. The department filed a 1275 PC bail hold, which places conditions on bail by requiring the defendants to prove funds used to secure bail does not come from their alleged illegal activity. The defendants were able to demonstrate bail funds were not from illegal activity. The defendants are scheduled to appear in court again on October 24, 2016.

Hospitals Continue Overuse of Antibiotics

Between 2006 and 2012, antibiotic use in hospitals in general did not change, and the use of a class of drugs tied most closely to antibiotic resistance actually increased, according to a new study published in the JAMA Internal Medicine and reported in Reuters Health.

“We believe the increases in the use of more powerful and ‘last resort’ antibiotics should prompt further exploration and, where indicated, actions to improve the use of these antibiotics,” said lead author James Baggs, of the U.S. Centers for Disease Control and Prevention in Atlanta.

“While the optimal level of antibiotic use or distribution of classes is not really known for every hospital, we know from other studies that inpatient prescribing of antibiotics for some infections is often inappropriate,” Baggs told Reuters Health by email.

The researchers reviewed adult and pediatric antibiotic use from 2006 to 2012 in 300 participating acute care hospitals. More than 34 million patients were discharged from these hospitals over the six-year period.

Over the whole period, 55 percent of patients left the hospital having taken at least one dose of an antibiotic. Overall, for every 1,000 days of hospitalization, 775 days included antibiotic therapy.

“In some cases, providers might be unaware of treatment guidelines,” Baggs said. “In others, infections are misdiagnosed, for example, a provider thinks a patient has an infection when they do not. We also know that in many cases for hospitalized patients, antibiotics are started before all of the clinical information is available.”

Although overall antibiotic use stayed level over time, use of third- and fourth-generation cephalosporins, macrolides, glycopeptides, carbapenems and tetracyclines increased significantly, as reported September 19 in JAMA Internal Medicine.

“In the hospital, where the sickest patients are, there’s been an increase in broad-spectrum antibiotics,” said Dr. Ateev Mehrotra of Harvard Medical School, who coauthored a commentary in the journal.

Broad-spectrum antibiotics act against a wide variety of bacteria. “Those are the big guns, and with increased use of them the worry is that that’s leading to the bacteria that’s broadly resistant,” Mehrotra said.

Antibiotic overuse has been a problem for decades, Mehrotra told Reuters Health by phone.

“We don’t believe the reason broad spectrum antibiotics are overused is that physicians aren’t educated,” he said. “Doctors are human, they’re worried, they’re behind, they’re concerned about what the patient wants.”

“What we’re proposing is that the strategies to address this should come from a psychological perspective,” and should target doctors who give out the most antibiotics, he said. If social pressure leads to overprescribing, maybe it can also curb prescribing rates.

“Send them an email or letter saying, you’re not a top performer, why is that,” Mehrotra said.

Antibiotic use guidelines are already in place and don’t need to be changed, he said.

WCIRB Study Shows Decline in Drug Spending

Despite a decline since 2013, pharmaceutical costs for California workers’ compensation indemnity claims at six months post injury increased by 217% over a ten-year period from 2005 through 2014. For claims lasting ten years or more, drugs account for 37% of all medical costs, contributing to California’s rank as the state with the longest durations for workers’ compensation claims in the nation.2

Although many factors have contributed to the long-term escalation of workers’ compensation drug costs, there are concerns in California as well as in other states about the possible impact of physician drug dispensing. This concern stems from a potential incentive for physicians, some of whom have purchased drugs wholesale, to dispense drugs to injured workers and then charge for those drugs on a retail basis.

A 2006 study by the Commission on Health and Safety and Workers’ Compensation revealed that 50% of all drug payments were made to physicians dispensing repackaged drugs resulting in $223 million in additional costs to workers’ compensation payers. This practice involved prescribing repackaged drugs at higher costs than the same drugs available at pharmacies.

Given that a 2002 Appellate Court Case in San Diego upheld physicians’ right to dispense drugs, the California Division of Workers’ Compensation addressed this issue in March 2007 through an administrative regulation which equalized payment levels for repackaged physician-dispensed drugs and drugs dispensed by pharmacies. This change appeared to reduce physician dispensing for some drugs while opening the door for dispensing of compounds not covered by the California Medi-Cal-based pharmacy fee schedule applicable to pharmaceuticals in the California system.

To update the situation, the WCIRB has released a new report entitled Patterns of Drug Dispensing in California Workers Compensation, which analyzed $500 million in workers’ compensation pharmaceutical payments from July 2012 through December 2015. WCIRB researchers used reported medical payment data representing more than 90% of the California workers’ compensation insurance market.

This study shows that the share of pharmacy payments directly to dispensing physicians dropped by 20% over the 42-month period. Given that the unit amounts paid to physicians remained at consistent levels during this period, the reduction in providers’ share of overall drug payments was driven by a lower number of prescriptions or utilization.

This decline in payments made to dispensing physicians occurred across all major types of drugs and was especially apparent for opiate analgesics, the most prominent type of workers’ compensation drug. For base substances used for compound drugs, the share paid directly to physician dispensers decreased by approximately 50%.

Despite the overall drop in payment shares, physicians received higher per transaction reimbursements for specific drugs, including some opiate analgesics and stomach discomfort medications. In addition, provider physicians generally dispensed the most expensive drugs within these categories, although lower cost therapeutic equivalents were often available in pharmacies.

These results help explain WCIRB findings showing a 28% reduction in drug spending per claim from the second half of 2012 through the second half of 2015. This trend may be attributed to many factors, including the introduction of Independent Medical Review and the greater attention across the country as to the potential overuse of opiates. This study suggests that the reduction in drug payments to physician dispensers may be another underlying factor in the overall decline in drug costs per claim over the last several years.

Hearing Set on Proposed RTW Supplement Program Rules

The Return-to-Work Supplement Program was established by the Legislature in Labor Code section 139.48, part of Senate Bill 863 to provide supplemental payments to workers whose Workers’ Compensation permanent disability benefits are disproportionately low in comparison to their earnings loss.

After Labor Code section 139.48 took effect on January 1, 2013, the Department, in coordination with the Commission on Health and Safety and Workers’ Compensation, commissioned an implementation study from the Rand Corporation. Guided by the Rand study, which was completed in February 2014, the Department developed and adopted California Code of Regulations, title 8, sections 17300 through 17310 to implement the RTWS Program. These regulations went into effect on April 6, 2015, and the Department began accepting applications for RTWS benefits on April 13, 2015.

The California Applicants’ Attorneys Association “CAAA” then petitioned the Director of Industrial Relations in accordance with Government Code section 11340.6 asking for the changes which are the subject matter of these amendments.

CAAA’s petition stated that the requested extension to the application deadline was necessary, because injured workers who received a voucher on or before the April 13, 2015 implementation date of the RTWS application process would no longer be able to apply for an RTWS benefit after April 13, 2016. This was despite the fact that those individuals had not received notice of their eligibility to apply for an RTWS benefit when they received their Vouchers.

CAAA’s petition also notes that the Voucher form, which is supposed to provide notice of eligibility to apply an RTWS benefit, was not updated to include that notice until approximately December 1, 2015. Moreover, while section 17303 required claims administrators to provide notice of eligibility via a cover sheet accompanying all Vouchers issued until the Voucher form was amended by DWC, the Department has been informed that at least some vouchers issued prior to December 1, 2015 were not accompanied by the required notice.

CAAA believes that the lower than expected number of applicants to the RTWS Program in 2015 (less than 12,000 when at least 24,000 were projected by the Rand study which the Department relied on when developing the Program) was largely due to this lack of notice of eligibility. The Department conducted a public hearing on CAAA’s petition on April 15, 2016, and determined to proceed with rulemaking to amend section 17304.

The proposed amendment to section 17304 extends the RTWS application deadline for individuals who became eligible for the benefit prior to December 1, 2015, to address inadequate notice to some individuals within that group of their entitlement to the RTWS benefit.

A public hearing has been scheduled at 10 a.m. on Monday, October 31, 2016, in Room 7, second floor of the Elihu Harris Building, 1515 Clay Street, Oakland, CA 94612. Members of the public may also submit written comments until 5 p.m. that day.

Written comments can be sent by email to LC139.48Comments@dir.ca.gov or by fax to (510) 286-6997.

The proposed amendment, notice and the California Applicants’ Attorneys Association (CAAA) RTW Petition and Notice of Public Hearing on Petition to Amend Regulations can be found on the DIR website.

Claimant Illegal Drug Use – What Are the Odds?

The connection between opiate pain pills and heroin addiction is now reached epidemic proportions according to state and federal health regulators. Yet it is uncommon for anyone in the workers’ compensation claim industry to be aware of even a single case where an injured worker is involved in heroin or concurrent use of illegal substances. What what are the odds that workers’ compensation claimants are free of illegal drug use?

A new study published in Spine, concludes that the odds are fairly high that people living with chronic low back pain (cLBP) are more likely to use illicit drugs — including marijuana, cocaine, heroin, and methamphetamine — compared to those without back pain.

In addition, cLBP patients with a history of illicit drug use are more likely to have a current prescription for opioid analgesic (pain-relieving) drugs, according to the new research by Dr. Anna Shmagel of University of Minnesota, Minneapolis, and colleagues. While it’s not clear which direction the association runs, the patterns of illicit drug use may have implications for decisions about prescribing opioids for patients with back pain.

The researchers analyzed survey responses from more than 5,000 US adults (aged 20 to 69) from a nationally representative health study (the 2009-2010 National Health and Nutrition Examination Survey, or NHANES).

About 13 percent of respondents met the study definition of cLBP — back pain present for three months or longer. The confidential survey also asked participants about their use of illicit drugs — marijuana, cocaine, heroin, and methamphetamine.

The results suggested that back pain was linked to higher rates of illicit drug use. About 49 percent of adults with cLBP said they had ever used illicit drugs, compared to 43 percent of those without cLBP. Rates of current illicit drug use (within the past 30 days) were also higher in the cLBP group: 14 percent versus nine percent.

All four specific drugs in the survey were more commonly used by respondents with cLBP. Rates of lifetime use were about 46.5 versus 42 percent for marijuana, 22 versus 14 percent for cocaine, nine versus five percent for methamphetamine, and five versus two percent for heroin. After adjustment for other factors, participants with cLBP were more than twice as likely to report methamphetamine and heroin use.

The results also suggested a link between illicit drugs and prescription opioids among patients with cLBP. Subjects who had ever used illicit drugs were more likely to have an active prescription for opioid analgesics: 22.5 percent versus 15 percent. Current illicit drug users were also more likely to have an opioid prescription, although that difference was not statistically significant.

Prescription opioids are widely used by patients with cLBP, raising concerns about addiction, misuse, and accidental overdose. Previous studies have found that people with a history of illicit drug use are more likely to misuse prescription opioids. The new study is one of the first to focus on rates of illicit drug use among Americans with cLBP.

The nationwide data show that people with cLBP have higher rates of illicit drug use, and those with a past history of illicit drug use are more likely to be current users of opioid analgesics. The researchers note some important limitations of their study–including a lack of data on whether illicit drug use occurred before or after cLBP. They also suggest that the true scope of the problem may be even greater, since NHANES excludes some groups at high risk of illicit drug use.

Pending further research, doctors may want to consider theses associations when evaluating pain relief options for patients with cLBP, Dr. Shmagel and coauthors believe. They write, “As we face a prescription opioid addiction epidemic, careful assessment of illicit drug use history may aid prescribing decisions.”

Workers’ Compensation Enters “Soft Market Phase”

The workers’ compensation market has likely entered a soft market phase based on a declining trend in price increases that began in 2013, according to a new special report from A.M. Best.

The Best’s Special Report titled, “State Funds’ Net Premiums Written Increased for Fifth Consecutive Year In 2015,” cited rate declines in the first quarter of 2015 that have persisted through the second quarter of 2016, in tandem with the more competitive environment in property/casualty commercial lines in general.

This conclusion was drawn as part of A.M. Best’s annual report on the state workers’ compensation funds sector. Net premiums written (NPW) within this segment increased for the fifth consecutive year in 2015, growing 2.4% to $8.6 billion, the highest premium level since 2006, according to the report.

Although underwriting leverage measures for the competitive state funds composite are at low levels and indicate solid capitalization, the report cites concerns going forward such as the recent declining trend in workers’ compensation pricing, the prolonged low interest rate environment, the potential for less favorable reserve development and the uncertainties relating to potential workers’ compensation legislation and health care reform.

State funds mainly compete for workers’ compensation business while also serving as their respective state’s guaranteed market. Some businesses that find it more difficult to afford or secure coverage in the voluntary market during hard market conditions often turn to state funds. This was likely a contributing factor to the growth of state funds over the past several years.

Collectively, state funds’ NPW equated to 18% of the total U.S. workers’ compensation premium in 2015, flat in comparison with 18% in 2014, but above a low of 15% in 2011. The significance of state funds also is apparent in their respective state market shares. For 2015, seven of the 18 state funds had market shares of at least 50% in their respective states and each one ranked first in its state based on direct premiums written.

Former Assemblyman Thomas Calderon Sentenced in Bribery Case

Thomas M. Calderon, a former member of the California State Assembly who became a political consultant, was sentenced this week to one year and one day of incarceration after he pleaded guilty to money laundering for allowing bribe money to be funneled through his firm.

Tom Calderon was sentenced by United States District Judge Christina A. Snyder, who ordered that the sentence be served half in federal prison and half in home detention. In addition to the period of incarceration, Judge Snyder ordered Tom Calderon to serve 100 hours of community service.

Tom Calderon, 62, of Montebello, pleaded guilty on June 6 to one count of money laundering and admitted that he agreed to conceal bribe payments coming from two undercover FBI agents by having the money go through his political consulting company, the Calderon Group.

The bribes were made to Tom Calderon’s brother, Ronald S. Calderon, who at the time was a California State Senator. Ron Calderon pleaded guilty on June 21 and admitted accepting bribes from the undercover agents and a businessman in exchange for performing official acts as a legislator. Ron Calderon, 59, also of Montebello, is scheduled to be sentenced by Judge Snyder next Monday, although he has asked to continue his sentencing date.

When he pleaded guilty, Tom Calderon specifically admitted that in 2013 he deposited a $30,000 bribe payment from an undercover agent into the Calderon Group’s bank account and then wrote a $9,000 check to Ron Calderon’s daughter.

“Tom Calderon was all too aware of the bribe payments to his brother and that his brother had agreed to a quid pro quo with the undercover agents,” said United States Attorney Eileen M. Decker. “Tom Calderon facilitated these bribe payments by helping to conceal his brother’s corrupt activities from the public.”

“Today’s sentencing sends a message to those interested in using access to public office in order to reap personal benefits that they will be held responsible for their actions,” said Deirdre Fike, the Assistant Director in Charge of the FBI’s Los Angeles Field Office. “Mr. Calderon used his family ties to benefit personally at the expense of the constituents represented by his brother’s office.”

Tom Calderon and his brother were both indicted by a federal grand jury in 2014. Tom Calderon was charged with conspiring with his brother to commit money laundering and seven substantive counts of money laundering. The money laundering charge that Tom Calderon pleaded guilty to was count 22 in the indictment.

“IRS Criminal Investigation tirelessly untangled the web of illicit transactions that lead to Thomas Calderon being held accountable for his role in this scheme,” stated IRS Criminal Investigation’s Acting Special Agent in Charge, Anthony J. Orlando. “IRS CI remains committed to investigating those who engage in political corruption and tarnish our democratic system.”

Workers’ Comp “Opt-Out” Movement Faces Legal Setback

Two states have laws that allow employers to opt-out of the state-regulated workers’ compensation system: Oklahoma and Texas. Texas has always had this law; Oklahoma recently adopted a variation of it. Nearly 30 Oklahoma employers had been approved for the opt-out system by the end of 2014, with many others taking a wait-and-see approach. Tennessee lawmakers introduced their own version of opt-out legislation which failed to become law.

But now we are back to just one opt-out state – Texas.

The Oklahoma Supreme Court Tuesday struck down the “opt out” provision of the state’s workers’ compensation law, ruling it is an unconstitutional special law that gives employers the authority to single out injured workers for inequitable treatment.

In a 7-2 ruling, the state’s highest court said the “opt out” provision “creates impermissible, unequal, disparate treatment” of injured workers and “does not guarantee members of the subject class, all employees, the same rights when a work related injury occurs,” in violation of the Oklahoma Constitution. Only Texas and Oklahoma have “opt out” provisions in their workers’ compensation systems.

Oklahoma’s Opt Out Act allows employers to “opt out” of the state’s workers’ compensation system and create their own plan. But employers who create their own plans can include conditions for recovery that make it more difficult for an injured worker to recover for a work-related injury than someone covered by the state’s plan, according to the ruling.

“The statutory language itself demonstrates that injured workers under the Opt Out Act have no protection to the coverage, process or procedure afforded their fellow employees,” it says.

The case involves a work-related injury sustained by an employee of Dillard’s Department Stores, Jonnie Yvonne Vasquez, who alleged she injured her neck and shoulder while lifting shoe boxes while working on Sept. 11, 2014. The ruling states that it applies to Vasquez’s case as well as all other cases on appeal and pending before the Workers Compensation Commission. Only 65 employers have elected to leave the state’s workers’ compensation system and create their own plans, said Vasquez’s attorney, Bob Burke of Oklahoma City.

In a dissenting opinion, Justices James Winchester and Steven Taylor said they would not invalidate the “opt out” provisions but would require the Workers Compensation Commission to determine whether an employee covered by an employer’s workers’ compensation plan was denied benefits the employee would have received under the state’s plan and require the employer plan to meet the requirements of the Opt Out Act.

In a statement, Oklahoma Attorney General Scott Pruitt said the Supreme Court’s ruling was “out of touch” and an attempt to reverse legislative actions that he said had lowered the cost of workers’ compensation insurance in the state. “Unfortunately, today’s decision is yet another action by the Oklahoma Supreme Court that dismantles these reforms piece by piece,” Pruitt said.

The ruling is the latest setback for sweeping Oklahoma workers’ compensation guidelines adopted by the Legislature in 2013. In April, the Supreme Court invalidated provisions that allowed deferral of payments for permanent partial disability for workers who eventually return to their jobs.

Revamping the state’s workers’ compensation system has been a priority for Republican legislative leaders who claim the state’s previous system was a detriment to business and industry in the state. Republican Gov. Mary Fallin has supported changes in the law.

But Burke said 38 separate provisions of the 2013 workers’ compensation law have been found unconstitutional, inoperable or invalid since they went into effect.

“It’s a great victory for the working men and women of this state,” Burke said. “We can’t allow the injured worker to be royally shafted like this.”